---
title: "NORDIC BIOTECH VENTURE FUND II K/S — Ownership Dossier"
canonical: https://whiteintel.dev/entity/25fc0edb-bb3d-55f9-95b6-80a67cfbbf33
json: https://whiteintel.dev/api/public/dossier/25fc0edb-bb3d-55f9-95b6-80a67cfbbf33
identifier: sec:0001428841
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# NORDIC BIOTECH VENTURE FUND II K/S

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001428841`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/25fc0edb-bb3d-55f9-95b6-80a67cfbbf33  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/25fc0edb-bb3d-55f9-95b6-80a67cfbbf33  

## Ownership & control

### Holdings / subsidiaries

- **TG THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/9c13e806-71d9-5ea4-8db4-d751fc718108

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NORDIC BIOTECH VENTURE FUND II K/S**. Human view: https://whiteintel.dev/entity/25fc0edb-bb3d-55f9-95b6-80a67cfbbf33 · Structured JSON: https://whiteintel.dev/api/public/dossier/25fc0edb-bb3d-55f9-95b6-80a67cfbbf33._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._